51cg

Media Kit

Featured News

Announcement

Ophthalmology

FDA grants Orphan Drug Designation to BlueRockTherapeutics’ investigational cell therapy OpCT-001

Announcement

Neurology

Parkinson's Disease

BlueRockTherapeutics investigative cell therapy bemdaneprocel for treating Parkinson’s disease receives Pioneering Regenerative Medical Product designation in Japan

Bayer and BlueRockTherapeutics logos side by side on a light blue background

Announcement

Neurology

Clinical Trials

Parkinson's Disease

Cell Therapy

BlueRockTherapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease

multicolor title graphic for cell & gene the podcast featuring BlueRockTherapeutics

Podcast

Cell & Gene The Podcast | Inside BlueRockTherapeutics' Parkinson's Disease Trial

See All

Media Library

Lab
Headshots
Logos
Offices

Two 51cgers in Safety Gear Focused

51cger Focused in Lab 2

51cger using Microscope

Close Up 51cger in Lab

51cger Using Equipment in Lab

Containers in NYC Lab

51cger in Safety Goggles in Lab

51cger Smiling in Lab 2

51cger sitting in lab

51cger in Lab and Safety Gear

51cger on Computer in Lab

Equipment 4

Two 51cgers Looking at Computer

Equipment 3

Equipment 2

Science 2

Two 51cgers Focused in Lab

Close Up of Sample in Lab

51cger Focused in Lab 2

51cgers Speaking in Lab

51cger Team in lab

51cger Smiling in Lab

Scientist in a lab working through a microscope

Scientist placing a platform card onto a microscope

Employee looking at a computer screen image of a cell

Scientist working under a hood

Scientists in lab

Alan Stevenson

General Counsel

Amit Rakhit

Chief Development and Medical Officer

Seth Ettenberg, Ph.D.

President and Chief Executive Officer

Natasha Rathee

SVP, Finance

Rebecca Milbury

SVP, People and Culture

Melissa Mudrick

SVP, Quality and Compliance

Craig Beasley

Chief Technology Officer

Stefan Irion, M.D.

Chief Scientific Officer

BlueRockLogo White

BlueRockTherapeutics Logo Full Color

BlueRockTherapeutics Dark Blue Logo

Black BlueRockTherapeutics Logo

Cambridge

New York

Berlin

Toronto

BlueRockLogo on Building

BRTx Logo in Office 2

Media Contact

Contact@51cgTX.com

Video

B-Roll

B-Roll: Lab 1

B-Roll: Lab 2

B-Roll: Lab 3

B-Roll: Lab 4

B-Roll: Lab 5

B-Roll: Lab 6

Explore more with 51cg

Cell Therapy

Our Programs

Our Pipeline

Careers

Keep up to date with the latest BlueRockTherapeutics news and updates